carbamazepine has been researched along with Myasthenia Gravis in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied total serum levels of carbamazepine (CBZ) serially, before and after five PEX cycles, in an epilepsy patient who underwent PEX for myasthenia gravis." | 7.73 | Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy. ( Ahmed, SN; Holt, A; Siddiqi, ZA, 2005) |
| "We studied total serum levels of carbamazepine (CBZ) serially, before and after five PEX cycles, in an epilepsy patient who underwent PEX for myasthenia gravis." | 3.73 | Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy. ( Ahmed, SN; Holt, A; Siddiqi, ZA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCauley, S | 1 |
| Thiraviaraj, A | 1 |
| Kurian, MA | 1 |
| King, MD | 1 |
| Rasmussen, M | 1 |
| Siddiqi, ZA | 1 |
| Holt, A | 1 |
| Ahmed, SN | 1 |
| O'Sullivan, SS | 1 |
| Mullins, GM | 1 |
| Neligan, A | 1 |
| McNamara, B | 1 |
| Galvin, RJ | 1 |
5 other studies available for carbamazepine and Myasthenia Gravis
| Article | Year |
|---|---|
PRE-OPERATIVE CARBAMAZEPINE-INDUCED HYPONATRAEMIA: SHOULD WE ACCEPT A RESET HYPO-OSMOLAR BASELINE AND PROCEED WITH SURGERY?
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Myasthenia Gravis; Pr | 2017 |
Antibody positive myasthenia gravis following treatment with carbamazepine--a chance association?
Topics: Antibodies, Antinuclear; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partia | 2003 |
Carbamazepine and myasthenia gravis.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Female; Humans; Myasthenia Gravis; Seizures | 2004 |
Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Comorbidity; Epilepsy; Female; Humans; Myasthenia Gravis; Pla | 2005 |
Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis.
Topics: Alopecia Areata; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Carbamazepine; Female | 2007 |